PhenomeX Inc. Common Stock
CELL
CELL was delisted on the 29th of September, 2023.
76 hedge funds and large institutions have $1.32B invested in PhenomeX Inc. Common Stock in 2020 Q3 according to their latest regulatory filings, with 76 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SUT
SC US (TTGP)
Menlo Park,
California
|
+$511M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
+$65.6M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$47.4M |
| 4 |
BlackRock
New York
|
+$40.9M |
| 5 |
JP Morgan Chase
New York
|
+$40.7M |
Top Sellers
CELL Hedge Fund Activity: Q3 2020 in Review
76 of the 4,957 institutional investors tracked by Wall St. Rank reported a position in PhenomeX Inc. Common Stock (CELL) for Q3 2020, worth a combined $1.32B.
Buyers outnumbered sellers: 76 funds opened new CELL positions and 0 closed out — a net gain of 76 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was SC US (TTGP), opening a new position worth an estimated $511M.
- 76 institutional investors held PhenomeX Inc. Common Stock (CELL) as of Q3 2020, up from 0 in Q2 2020.
- Funds reported $1.32B of PhenomeX Inc. Common Stock stock for Q3 2020.
- 76 funds opened new PhenomeX Inc. Common Stock positions in Q3 2020 and 0 closed out, a net change of +76 holders.
- The largest PhenomeX Inc. Common Stock buyer in Q3 2020 was SC US (TTGP), an estimated $511M added.
Based on aggregated 13F filings for Q3 2020.